Ludwig Enterprises (LUDG) Amortization of Deferred Charges (2023 - 2024)
Ludwig Enterprises (LUDG) reported Amortization of Deferred Charges of $989574.0 for Q4 2024, up 333.19% on a YoY basis from $228437.0 in Q1 2024, and up 14036.77% quarter-over-quarter from $7000.0 in Q2 2024.
Ludwig Enterprises (LUDG) Amortization of Deferred Charges (2023 - 2024) Analysis & Trends
Ludwig Enterprises has reported Amortization of Deferred Charges for 2 years, with the latest figure at $989574.0 in Q4 2024.
- For the quarter ending Q4 2024, Amortization of Deferred Charges rose 333.19% year-over-year to $989574.0; the trailing twelve-month figure through Dec 2024 stood at $1.2 million (changed N/A YoY), and the FY2024 full-year result was $1.0 million, up 94.14% from the prior year.
- Amortization of Deferred Charges for Q4 2024 stood at $989574.0, up from $7000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $989574.0 in Q4 2024, with the low at $7000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Ludwig Enterprises | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 989,574.00 |
| Dec 31, 2024 | 989,574.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Dec 31, 2023 | 228,437.00 |
| Dec 31, 2023 | 228,437.00 |
| Sep 30, 2023 | 61,733.00 |
| Sep 30, 2023 | 61,733.00 |
| Jun 30, 2023 | 220,044.00 |
| Jun 30, 2023 | 220,044.00 |